Related Experiment Video
Updated: Apr 16, 2026

08:57
Scalable Syntheses of Graphene Oxide and Reduced Graphene Oxide using Cascade Design Oxidation and Highly Basic Reduction Reactions
Published on: July 3, 2025
2.5K
Graphene-oxide stabilization in electrolyte solutions using hydroxyethyl cellulose for drug delivery application
Hanieh Mianehrow1, Mohamad Hasan Mohamadzadeh Moghadam1, Farhad Sharif1
1Department of Polymer Engineering and Colour Technology, Amirkabir University of Technology, 15875-4413 Tehran, Iran.
International Journal of Pharmaceutics
|March 5, 2015
Summary
Hydroxyethyl cellulose (HEC) stabilizes graphene oxide (GO) nanohybrids in physiological solutions for drug delivery. The nanohybrid shows high drug loading and good biocompatibility, enabling targeted delivery and controlled release.
Area of Science:
- Materials Science
- Nanotechnology
- Biomedical Engineering
Background:
- Graphene oxide (GO) has potential in drug delivery but requires stabilization in physiological environments.
- Hydroxyethyl cellulose (HEC) is explored as a stabilizing agent for GO-based nanostructures.
Purpose of the Study:
- To stabilize graphene oxide (GO) using hydroxyethyl cellulose (HEC) for targeted drug delivery applications.
- To evaluate the stability, drug loading/release, and biocompatibility of the GO-HEC nanohybrid.
Main Methods:
- Stabilization of GO using HEC in physiological solutions.
- Assessment of GO suspension stability via UV-vis spectroscopy, AFM, and zeta potential.
- Study of folic acid (FA) loading and release kinetics from the GO-HEC nanohybrid.
- Cytotoxicity evaluation of the nanohybrid.
Main Results:
- HEC effectively stabilized GO in electrolyte solutions, with stabilization mechanism dependent on HEC content.
- The GO-HEC nanohybrid demonstrated high loading capacity for folic acid.
- HEC content influenced the nanohybrid's applicability for controlled or targeted drug release.
- Cytotoxicity assays confirmed good biocompatibility of the GO-HEC nanohybrid.
Conclusions:
- HEC-stabilized GO nanohybrids are suitable for drug delivery applications.
- The nanohybrid offers high drug loading capacity and controllable release profiles.
- The GO-HEC nanohybrid exhibits good biocompatibility, supporting its potential as a drug carrier.

